T-cell acute lymphoblastic leukemia foll
โ
Kaplinsky, Chaim ;Frisch, Amos ;Cohen, Ian J. ;Goshen, Yacov ;Jaber, Lutfi ;Yani
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 420 KB
## Abstract Multiple studies have documented an increased risk of secondary malignancies in patients receiving alkylating agents. Secondary leukemia following chemotherapy accounts for about 20% of all secondary neoplasms; most are acute nonlymphocytic. Secondary acute lymphoblastic leukemia has ra